Newer therapies for diabetes management.

Abstract

With the increasing global epidemic of diabetes, especially type 2 diabetes, all major pharmaceutical companies are focusing on new molecules for the treatment of diabetes and obesity. With the better management of diabetes (improved HbA1c values), the microvascular complications have significantly reduced over the past two decades. This has been achieved without increasing hypoglycemia especially with newer technological advances (discussed at length in chapters 12 and 13 in this yearbook). We review here the abstracts related to the newer molecules that are being investigated in the management of diabetes. We searched more than 400 articles on newer agents published from July 2012 to June 2013, of which the best 19 abstracts are discussed. Also, we briefly mention newer insulin analogs and alternate insulin delivery methods, as this topic is discussed at length by colleagues in chapter 5 of this yearbook.